U.S. Markets open in 5 hrs 35 mins

Celgene Earnings, Revenue Beat in Q1

Investing.com - Celgene (NASDAQ:CELG) reported first quarter earnings that Beat analysts' expectations on Thursday and revenue that topped forecasts.

The firm reported earnings per share of $2.55 on revenue of $4.03B. Analysts polled by Investing.com expected EPS of $2.45 on revenue of $4.01B. That compared to EPS of $2.05 on revenue of $3.54B in the same period a year earlier. The company had reported EPS of $2.39 on revenue of $4.04B in the previous quarter.


Celgene follows other major Healthcare sector earnings this month


On April 16, J&J reported first quarter EPS of $2.1 on revenue of $20.02B, compared to forecasts of EPS of $2.04 on revenue of $19.61B.

Novartis ADR earnings Beat analysts' expectations on Wednesday, with first quarter EPS of $1.21 on revenue of $11.11B. Investing.com analysts expected EPS of $1.1 on revenue of $11.4B

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Related Articles

Battle for Hong Kong Airlines pulls complex HNA holdings into daylight

Judge gives U.S. six months to identify separated migrant children

Facebook files lawsuit against New Zealand company, three people